Business of the House
Debate between Penny Mordaunt and Daniel Zeichner(1 year, 5 months ago)
Commons ChamberRead Full debate Read Hansard Text Read Debate Ministerial Extracts
Daniel Zeichner (Cambridge) (Lab)
The UK life sciences sector excelled during the covid crisis, and we applauded it for that, but since then the picture has been less rosy. The number of clinical trials being undertaken has fallen back badly, and we have fallen down the international league table. The Government are aware of this; they have appointed Lord O’Shaughnessy to conduct a review, and his findings are expected soon. Will the Leader of the House ensure that a statement is made at that time, so that there can be a proper interrogation about his conclusions?
Penny Mordaunt
As the hon. Gentleman will know, this important matter is a priority for the Government. Our future national prosperity depends on it, and we also want to ensure that the people of this country benefit from the life sciences sector and innovations can be taken up quickly. I shall certainly ensure that my noble Friend Lord O’Shaughnessy has heard the hon. Gentleman’s request.